ClinConnect ClinConnect Logo
Search / Trial NCT06775821

Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer

Launched by FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL UNIVERSITY · Jan 11, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Abdominal Aortic Aneurysm Primary Lung Cancer Epidemiological Studies Prevalence

ClinConnect Summary

This clinical trial is looking into the relationship between abdominal aortic aneurysms (AAA) and primary lung cancer. Researchers have noticed that many patients with lung cancer are also found to have AAA, but the exact link between the two conditions is not well understood. The goal of this study is to gather more information about how common AAA is in people with lung cancer and to investigate why this might be happening. By doing so, the researchers hope to improve screening and prevention strategies for AAA in lung cancer patients, which could help with their overall treatment and survival.

To join this study, participants need to have a confirmed diagnosis of primary lung cancer. However, those who do not want to undergo abdominal imaging tests to check for AAA will not be included. As the trial is currently recruiting, eligible patients can expect to be involved in a multi-center investigation that gathers important data over time. This study aims to provide valuable insights that could benefit lung cancer patients in the long run.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients diagnosed with primary lung cancer through clinical or pathological examination
  • Exclusion Criteria:
  • Patients diagnosed with primary lung cancer who refuse to undergo abdominal aortic imaging screening.

About First Affiliated Hospital Of Kunming Medical University

The First Affiliated Hospital of Kunming Medical University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on a wide range of medical disciplines, facilitating cutting-edge studies that aim to improve patient outcomes and contribute to the global body of medical knowledge. With a commitment to ethical practices and rigorous scientific methodologies, the hospital collaborates with healthcare professionals and researchers to drive progress in treatment options and therapeutic advancements.

Locations

Kunming, Yunnan, China

Kunming, Yunnan, China

Patients applied

0 patients applied

Trial Officials

Xu-Dong Xiang, MPhil

Study Director

The Third Affiliated Hospital of Kunming Medical University

Ding-yun You, Ph.D.

Study Director

Kunming Medical University

Yun-fei Shi, MPhil

Study Director

First Affiliated Hospital of Kunming Medical University

Gui-ming Liu, MBBS

Principal Investigator

The Third Affiliated Hospital of Kunming Medical University

Qing-yan Ma, MBBS

Principal Investigator

Kunming Medical University

Qian Zhu, MBBS

Principal Investigator

The Third Affiliated Hospital of Kunming Medical University

Kai-xiong Qing, ph.D.

Study Chair

The Third Affiliated Hospital of Kunming Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported